{"filing":{"accession_number":"0001728117-26-000106","cik":"0001728117","ticker":"GOSS","company_name":"Gossamer Bio, Inc.","form":"8-K","filing_date":"2026-09-28","report_date":"2026-09-25","primary_document":"goss-20260925.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000106/goss-20260925.htm"},"events":[{"id":35423,"run_id":32625,"accession_number":"0001728117-26-000106","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"The disclosure reports that Gossamer Bio has regained compliance with Nasdaq's minimum bid price requirement (Rule 5450(a)(1)) following a prior non-compliance notice dated April 8, 2026, and a 1-for-80 reverse stock split executed on September 10, 2026. This is a delisting-risk resolution: the company was at risk of delisting due to failure to maintain a $1.00 minimum bid price for 30 consecutive business days, but has now cured that deficiency through the reverse split and price recovery. Material to investors as it directly addresses the company's continued listing status.","company_name":"Gossamer Bio, Inc.","ticker":"GOSS","filing_date":"2026-09-28","form":"8-K","submitted_at":null,"items":[{"id":39461,"accession_number":"0001728117-26-000106","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports that Gossamer Bio has regained compliance with Nasdaq's minimum bid price requirement (Rule 5450(a)(1)) following a prior non-compliance notice dated April 8, 2026, and a 1-for-80 reverse stock split executed on September 10, 2026. This is a delisting-risk resolution: the company was at risk of delisting due to failure to maintain a $1.00 minimum bid price for 30 consecutive business days, but has now cured that deficiency through the reverse split and price recovery. Material to investors as it directly addresses the company's continued listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T20:04:29.780943+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":39461,"accession_number":"0001728117-26-000106","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports that Gossamer Bio has regained compliance with Nasdaq's minimum bid price requirement (Rule 5450(a)(1)) following a prior non-compliance notice dated April 8, 2026, and a 1-for-80 reverse stock split executed on September 10, 2026. This is a delisting-risk resolution: the company was at risk of delisting due to failure to maintain a $1.00 minimum bid price for 30 consecutive business days, but has now cured that deficiency through the reverse split and price recovery. Material to investors as it directly addresses the company's continued listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T20:04:29.780943+00:00","company_name":"Gossamer Bio, Inc.","ticker":"GOSS","filing_date":"2026-09-28"}]}